US · APYX
Apyx Medical Corporation
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Clearwater, FL 33760
- Website
- apyxmedical.com
Price · as of 2024-12-31
$3.06
Market cap 134.17M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $24.93 | +714.71% |
| Intrinsic Value(DCF) | $0.45 | -85.29% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $0.81 | $0.14 | |||
| 2011 | $1.29 | $0.08 | |||
| 2012 | $1.47 | $0.58 | |||
| 2013 | $0.00 | $1.40 | |||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $0.00 | $0.00 | |||
| 2016 | $0.23 | $0.00 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $7.20 | $51.81 | $1.82 | $12.28 | $0.00 |
| 2019 | $5.73 | $39.09 | $0.97 | $0.00 | $0.00 |
| 2020 | $11.54 | $31.32 | $0.55 | $0.12 | $0.00 |
| 2021 | $5.88 | $39.99 | $178.20 | $0.00 | $0.00 |
| 2022 | $2.79 | $21.45 | $3.83 | $0.00 | $0.00 |
| 2023 | $1.74 | $41.00 | $6.68 | $0.00 | $0.00 |
| 2024 | $1.12 | $24.93 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Apyx Medical Corporation's (APYX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $24.93
- Current price
- $3.06
- AI upside
- +714.71%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.45
-85.29% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| APYX | Apyx Medical Corporation | $3.06 | 134.17M | +715% | -85% | — | — | -1.69 | 2.80 | 0.83 | -2.79 | -7.60 | 2.80 | 61.04% | -39.18% | -48.78% | -115.17% | -88.10% | -32.70% | 2.73 | -3.19 | 5.26 | 4.40 | -0.42 | 2222.00% | -811.00% | 22461.00% | -47.15% | -1.68 | -87.74% | 0.00% | 0.00% | 0.00% | -2.49 | -2.50 | 0.97 | -0.58 |
| ATOS | Atossa Therapeutics, Inc. | $4.43 | 38.15M | — | — | — | — | -3.65 | 1.30 | — | -0.80 | — | 1.30 | 0.00% | — | — | -31.39% | -1873.25% | -29.54% | 0.00 | — | 14.99 | 14.31 | 2.58 | -1667.00% | — | 45.00% | -22.60% | -4.23 | -1427.53% | 0.00% | 0.00% | 0.00% | -0.80 | -1.05 | — | 7.27 |
| LUCD | Lucid Diagnostics Inc. | $1.44 | 146.54M | +85,309% | -60% | — | — | -1.54 | 13.02 | 16.16 | -1.56 | — | 15.08 | -90.20% | -1059.64% | -1047.61% | -2956.43% | 5531.77% | -157.04% | 3.94 | -1771.23 | 1.07 | 0.97 | 0.02 | -1667.00% | 7900.00% | 3556.00% | -63.78% | -1.88 | 5379.70% | 0.00% | 0.00% | 0.00% | -1.50 | -1.54 | 15.90 | -12.37 |
| NSPR | InspireMD, Inc. | $1.78 | 75.42M | +1,242% | -35% | — | — | -3.72 | 3.30 | 16.99 | -2.61 | — | 3.30 | 21.49% | -478.00% | -456.63% | -84.68% | -1143.45% | -67.77% | 0.06 | — | 5.28 | 4.80 | 0.50 | -732.00% | 1296.00% | 3887.00% | -19.54% | -2.85 | -794.20% | 0.00% | 0.00% | 7.17% | -2.59 | -3.73 | 12.38 | -2.29 |
| PDEX | Pro-Dex, Inc. | $44.31 | 144.54M | +1,328% | +5% | -44% | +89% | 13.99 | 3.43 | 1.89 | 9.56 | 4.05 | 3.43 | 29.30% | 16.05% | 13.48% | 26.60% | 19.04% | 15.80% | 0.45 | 12.89 | 3.23 | 1.68 | 1.14 | 34500.00% | 2368.00% | -15613.00% | -2.33% | -0.11 | -7.00% | 0.00% | 0.00% | 2.79% | 12.63 | -46.10 | 2.03 | 6.19 |
| QIPT | Quipt Home Medical Corp. | $3.63 | 161.41M | +679% | +41,027% | -84% | — | -9.83 | 0.75 | 0.31 | 5.02 | -17.48 | 183.07 | 70.09% | -1.56% | -3.13% | -8.67% | -2.44% | -3.34% | 0.85 | -0.79 | 1.46 | 0.64 | 2.52 | 5625.00% | 3883.00% | 108.00% | 24.09% | 0.50 | 11.61% | 0.00% | 0.00% | 0.12% | -39.68 | 8.33 | 0.62 | 0.40 |
| RCEL | AVITA Medical, Inc. | $5.03 | 124.96M | +486% | -58% | — | — | -3.02 | -8.82 | 2.05 | -3.30 | — | -6.59 | 82.13% | -58.56% | -67.85% | 799.72% | 463.33% | -71.40% | -0.13 | -8.38 | 0.57 | 0.44 | 0.20 | -2720.00% | 1145.00% | -4647.00% | -21.25% | -0.50 | 344.68% | 0.00% | 0.00% | 27.27% | -3.12 | -4.19 | 1.83 | -10.70 |
| RPID | Rapid Micro Biosystems, I… | $4.33 | 191.92M | +463% | -78% | — | — | -2.22 | 1.38 | 3.71 | -1.28 | — | 1.38 | -0.39% | -177.96% | -167.16% | -48.50% | -155.83% | -38.81% | 0.08 | — | 4.61 | 3.32 | 0.23 | -1148.00% | 2457.00% | -300.00% | -43.71% | -2.51 | -142.09% | 0.00% | 0.00% | 0.00% | -1.19 | -1.31 | 2.12 | -4.66 |
| SERA | Sera Prognostics, Inc. | $2.29 | 86.17M | +1,463% | -17% | — | +2,648% | -4.35 | 3.00 | 1860.23 | -3.05 | — | 3.06 | -6.49% | -47577.92% | -42724.68% | -55.78% | -289.10% | -39.16% | 0.02 | -1308.39 | 1.92 | 1.87 | 0.10 | -1466.00% | -7484.00% | -4403.00% | -10.67% | -0.57 | -120.66% | 0.00% | 0.00% | 0.82% | -2.67 | -6.40 | 1270.67 | -3.22 |
| VANI | Vivani Medical, Inc. | $1.23 | 72.67M | — | — | — | — | -2.53 | 3.37 | — | -2.49 | — | 3.37 | 0.00% | — | — | -122.42% | -125.35% | -53.77% | 1.10 | — | 3.41 | 3.11 | -0.04 | -1400.00% | — | -1319.00% | -35.94% | -3.47 | -108.41% | 0.00% | 0.00% | 0.00% | -2.45 | -2.83 | — | -4.16 |
About Apyx Medical Corporation
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
- CEO
- Charles D. Goodwin
- Employees
- 220
- Beta
- 1.58
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.45 ÷ $3.06) − 1 = -85.29% (DCF, example).